Global Melanoma Therapeutics Market Status and Prospect, Forecast 2018 to 2026

Posted by Andreas Winkler on March 5th, 2018

Melanoma is a form of skin cancer that arises when pigment-producing cells mutates and become cancerous. Pigmented cells are found in skin and occur in other part of body such as intestine, and eyes. Melanoma is one of type of skin cancer ( is less common than basal cell and squamous cell skin cancer. However, melanoma is considered as dangerous type of skin cancer as these cancerous growths develop when unrepaired DNA damage to skin cells and they are likely to spread in the body. Melanoma is caused due to exposure to ultraviolet radiation form the sun and from tanning lamp.

Increasing prevalence of melanoma, skin allergies and skin cancer is expected to drive the growth of melanoma therapeutics market. Moreover, rising awareness about the melanoma globally, coupled with several government and non-profit organizations providing education and support services is anticipated to further drive growth of the global melanoma therapeutics market over the forecast period. Furthermore, increasing number of approvals for novel therapeutics is expected to boost the growth of melanoma therapeutics market over the forecast period.

A major factor restraining growth of the global melanoma therapeutics market is high cost for treatment.
However, technological advancements and innovations focusing on development of biologics for treatments is expected to create new opportunities for major players in the global melanoma therapeutics market over the forecast period.

The global melanoma therapeutics market report has been segmented on the basis of therapy type, stage, and region. On the basis of region, the global melanoma therapeutics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Do Inquiry of the Report Here:

North America market dominates the global melanoma therapeutics market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure and availability of skilled medical personnel and increasing number of skin cancer cases in the region. Europe accounts for second-largest revenue share contribution to the global melanoma therapeutics market, followed by markets in Latin America, Asia Pacific, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing investment by key market players in emerging market and increasing demand for cost-efficient therapeutics.

Some prominent players in the global sterilization equipment market are Amgen, Inc., F. Hoffman-La Roche Ltd., Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., AstraZeneca, AB Sciences, Celgene Corporation, Galectin Therapeutics, and Ziopharm Oncology, Inc.

Prudour Pvt. Ltd. ( is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. Prudour Pvt. Ltd. offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Krutika Bhoot
Prudour Pvt. Ltd. 420 Lexington Avenue, Suite 300 NY
10170 New York City
Phone: +1 347 826 1876

Like it? Share it!

Andreas Winkler

About the Author

Andreas Winkler
Joined: June 7th, 2017
Articles Posted: 1,295

More by this author